BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23241438)

  • 1. Down-regulation of heparanase leads to the inhibition of invasion and proliferation of A549 cells in vitro and in vivo.
    Chen Z; Zhu L; Li X; Tian H; Fang Y; Liu H; Li S; Li L; Yue W; Li W
    Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):188-93. PubMed ID: 23241438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma.
    Zhang Y; Li L; Wang Y; Zhang J; Wei G; Sun Y; Shen F
    Biochem Biophys Res Commun; 2007 Jun; 358(1):124-9. PubMed ID: 17467664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of exogenous expression of heparanase gene on invasive ability of colorectal cancer cell line HT29].
    Liu Y; Ding YQ; Xin XY; Han LF; Liang L
    Ai Zheng; 2005 Dec; 24(12):1427-30. PubMed ID: 16351786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells.
    Uno F; Fujiwara T; Takata Y; Ohtani S; Katsuda K; Takaoka M; Ohkawa T; Naomoto Y; Nakajima M; Tanaka N
    Cancer Res; 2001 Nov; 61(21):7855-60. PubMed ID: 11691803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of silencing heparanase expression with antisense oligodeoxynucleotide on invasive capability of human esophageal squamous cancer cell line TE-13].
    Zhu H; Wang SJ; Wang SX; Meng XL; Wang YJ
    Ai Zheng; 2005 Dec; 24(12):1431-5. PubMed ID: 16351787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis.
    Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C
    Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo.
    Xiong Z; Lü MH; Fan YH; Cao YL; Hu CJ; Wu YY; Wang SM; Luo G; Fang DC; Li C; Yang SM
    Int J Oncol; 2012 May; 40(5):1601-9. PubMed ID: 22267022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase affects adhesive and tumorigenic potential of human glioma cells.
    Zetser A; Bashenko Y; Miao HQ; Vlodavsky I; Ilan N
    Cancer Res; 2003 Nov; 63(22):7733-41. PubMed ID: 14633698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
    Ilan N; Elkin M; Vlodavsky I
    Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of heparanase inhibition by RNA interference on proliferation, invasiveness and apoptosis of lung cancer cells].
    Zhang QF; Huang Q; Liu N; Jiang LL; Qiu XS; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):826-30. PubMed ID: 19159529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
    Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
    Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of heparanase gene expression by estrogen in breast cancer.
    Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
    Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
    Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
    Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.
    Goldshmidt O; Zcharia E; Abramovitch R; Metzger S; Aingorn H; Friedmann Y; Schirrmacher V; Mitrani E; Vlodavsky I
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10031-6. PubMed ID: 12097647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of heparanase in gastrointestinal cancer (Review).
    Naomoto Y; Takaoka M; Okawa T; Nobuhisa T; Gunduz M; Tanaka N
    Oncol Rep; 2005 Jul; 14(1):3-8. PubMed ID: 15944760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
    Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
    Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.